The Senate Health, Education, Labor and Pensions Committee today held a hearing for Alex Azar, President Trump’s nominee for secretary of Health and Human Services. Azar, former president of Lilly USA and deputy HHS secretary under the George W. Bush administration, faced a number of questions from senators about his ties to the pharmaceutical industry and how he would tackle high drug prices. “I believe I can bring the skills and experiences to the table that can help us address these issues, while still encouraging discovery so Americans have access to high quality care,” Azar said. Trump nominated Azar for HHS secretary earlier this month. Tom Price, M.D., resigned as HHS secretary on Sept. 29. Deputy Secretary Eric Hargan has been serving as acting secretary. Azar will need to testify before the Senate Finance Committee, which has not announced a hearing date, before the full Senate votes on his appointment.

Related News Articles

Headline
The Government Accountability Office this week
Insights and Analysis
Hospital and health system leaders shared how they are driving innovation to advance health and the patient experience at this week’s 20th Annual Not-for-…
Insights and Analysis
Also in this weekly roundup of nursing news: a nurse helps save the life of a man at the theatre, and executive moves in the field.
Headline
The AHA has elected to fill a vacancy on its Board of Trustees Sylvia Young, president and CEO of HCA Healthcare’s Continental Division.
Insights and Analysis
Also in this roundup of hospital and health system leadership changes: South Shore Hospital, South Weymouth, Mass., names new president; and West Boca (Fla.)…
Headline
The National Center for Healthcare Leadership is accepting nominations through June 7 for the 2019 Gail L. Warden Leadership Excellence Award.